Citation 78947

CAI,Y: FREDENHAGEN,A: HUG,P: MEYER,T: PETER,HH:. (1996). FURTHER MINOR METABOLITES OF STAUROSPORINE PRODUCED BY A STREPTOMYCES LONGISPOROFLAVUS STRAIN.. 49(6)

Citation Details

Title	FURTHER MINOR METABOLITES OF STAUROSPORINE PRODUCED BY A STREPTOMYCES LONGISPOROFLAVUS STRAIN.
Authors	CAI,Y: FREDENHAGEN,A: HUG,P: MEYER,T: PETER,HH:
Year	1996
Volume	49
Issue	6

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Streptomyces longisporoflavus (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	STREPTOMYCES ANTIBIOTIC TAN-1030-A,7-HYDROXY:	None
2	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC TAN-1030-A,7-HYDROXY:	ACTIVE
3	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC TAN-1030-A,7-HYDROXY:	WEAK ACTIVITY
4	PHOSPHORYLASE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC TAN-1030-A,7-HYDROXY:	ACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	STAUROSPORINE,4'-DEMETHYL-4'-HYDROXY-IMINO:	None
6	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STAUROSPORINE,4'-DEMETHYL-4'-HYDROXY-IMINO:	ACTIVE
7	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STAUROSPORINE,4'-DEMETHYL-4'-HYDROXY-IMINO:	ACTIVE
8	PHOSPHORYLASE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STAUROSPORINE,4'-DEMETHYL-4'-HYDROXY-IMINO:	ACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATACD SPECTRUM REPORTED FOR	STREPTOMYCES ANTIBIOTIC UCN-01	None
10	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC UCN-01	ACTIVE
11	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC UCN-01	ACTIVE
12	PHOSPHORYLASE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC UCN-01	ACTIVE
13	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STREPTOMYCES ANTIBIOTIC TAN-1030-A,7-OXO:	None
14	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC TAN-1030-A,7-OXO:	ACTIVE
15	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC TAN-1030-A,7-OXO:	ACTIVE
16	PHOSPHORYLASE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC TAN-1030-A,7-OXO:	ACTIVE
17	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STREPTOMYCES ANTIBIOTIC TAN-1030-A DERIVATIVE 5: DEMETHOXY: 2-PROPAN-2-YL:	None
18	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC TAN-1030-A DERIVATIVE 5: DEMETHOXY: 2-PROPAN-2-YL:	WEAK ACTIVITY
19	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC TAN-1030-A DERIVATIVE 5: DEMETHOXY: 2-PROPAN-2-YL:	INACTIVE
20	PHOSPHORYLASE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC TAN-1030-A DERIVATIVE 5: DEMETHOXY: 2-PROPAN-2-YL:	ACTIVE
21	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATACD SPECTRUM REPORTED FOR	STREPTOMYCES ANTIBIOTIC 8	None
22	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC 8	ACTIVE
23	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC 8	ACTIVE
24	PHOSPHORYLASE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC 8	ACTIVE
25	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATACD SPECTRUM REPORTED FOR	STREPTOMYCES ANTIBIOTIC 9	None
26	PROTEIN KINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC 9	ACTIVE
27	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC 9	ACTIVE
28	PHOSPHORYLASE KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC 9	ACTIVE
29	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STREPTOMYCES ANTIBIOTIC TAN-1030-A DERIVATIVE 5	None
30	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	STREPTOMYCES LONGISPOROFAVUS ANTIBIOTIC 7	None
31	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STAUROSPORINE,N-FORMYL:	None
32	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STAUROSPORINE,4'-NITRO:	None

Citation 78947

Citation Details

Summary

Organisms and Their Experiments (1)

Streptomyces longisporoflavus (STREPTOMYCETACEAE)

Show SPARQL Queries (1)

Query 1